🦠CDC Seeks Public Comment on Tuberculosis Drug Susceptibility Testing
Proposed Data Collection Submitted for Public Comment and Recommendations
Summary
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled, CDC Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing. CDC is requesting a three-year approval for extension of the currently approved project used to monitor and evaluate performances and practices among national laboratories' M. tuberculosis susceptibility testing.
Agencies
- Health and Human Services Department
- Centers for Disease Control and Prevention
Business Impact
$$ - Med
The proposed data collection by the CDC involves compliance and reporting requirements for laboratories involved in drug susceptibility testing for Mycobacterium tuberculosis. Business owners in clinical and public health laboratory sectors need to account for participation in compliance with this program, impacting operational practices and resources.